SCHEMBL25013468

SCHEMBL25013468

CCCc1nn(C)c2c(=O)[nH]c(-c3cc(C(C)=O)ccc3O)nc12

nearest known ligand 0.76

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 18/20 0.76
PDE6C P51160 2/20 0.76
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
ALDH1A1 P00352 1/20 0.56
HPGD P15428 1/20 0.56
PDE1A P54750 1/20 0.56
PDE1B Q01064 1/20 0.56
PDE1C Q14123 1/20 0.56
HDAC1 Q13547 8/20 0.56
HDAC6 Q9UBN7 8/20 0.56
HDAC2 Q92769 6/20 0.56
HDAC3 O15379 1/20 0.55
NCOR2 Q9Y618 1/20 0.55
MTOR P42345 1/20 0.54
PDE3B Q13370 2/20 0.54
PDE3A Q14432 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7961020 0.87 PDE5A (1.00) PDE5APDE6CKMT2AMEN1ALDH1A1
SCHEMBL1529 0.83 PDE5A (1.00) PDE5APDE6CKMT2AMEN1ALDH1A1
SCHEMBL931 0.82 PDE5A (0.68) PDE5APDE6CKMT2APDE1APDE1B
SCHEMBL28967164 0.82 PDE5A (0.62) PDE5APDE6CKMT2AMEN1ALDH1A1
SCHEMBL8802595 0.80 PDE5A (0.63) PDE5APDE6CKMT2AMEN1ALDH1A1
SCHEMBL7960838 0.79 PDE5A (0.86) PDE5APDE6CKMT2AMEN1ALDH1A1
SCHEMBL18714952 0.78 PDE5A (0.85) PDE5APDE6CKMT2AMEN1ALDH1A1
SCHEMBL30848766 0.78 PDE5A (0.78) PDE5APDE6CPDE1APDE1BPDE1C
SCHEMBL1409 0.78 PDE5A (0.78) PDE5APDE6CPDE1APDE1BPDE1C
SCHEMBL15996104 0.78 PDE5A (0.83) PDE5APDE6CKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230041334-A1 METHODS AND COMPOSITIONS FOR SMOKING CESSATION BEHAVIORAL DIAGNOSTICS, LLC (US) 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230041334-A1 METHODS AND COMPOSITIONS FOR SMOKING CESSATION PDE5A, PDE3A, PDE2A PDE5A 1/4885PDE6C 15/4885KMT2A 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.